RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nextgen Biomed Stock

Nextgen Biomed Equity 2025

Nextgen Biomed Equity

0 ILS

Ticker

NXGN.TA

ISIN

IL0010839301

In 2025, Nextgen Biomed's equity was 0 ILS, a 0% increase from the 0 ILS equity in the previous year.

Nextgen Biomed Aktienanalyse

What does Nextgen Biomed do?

Nextgen Biomed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Nextgen Biomed's Equity

Nextgen Biomed's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nextgen Biomed's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Nextgen Biomed's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Nextgen Biomed's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Nextgen Biomed’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Nextgen Biomed stock

What is the equity of Nextgen Biomed this year?

Nextgen Biomed has equity of 0 ILS this year.

What was the equity of Nextgen Biomed compared to the previous year?

The equity of Nextgen Biomed has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Nextgen Biomed?

A high equity is advantageous for investors of Nextgen Biomed as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Nextgen Biomed?

A low equity can be a risk for investors of Nextgen Biomed, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Nextgen Biomed affect the company?

An increase in equity of Nextgen Biomed can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Nextgen Biomed affect the company?

A reduction in equity of Nextgen Biomed can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Nextgen Biomed?

Some factors that can affect the equity of Nextgen Biomed include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Nextgen Biomed so important for investors?

The equity of Nextgen Biomed is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Nextgen Biomed take to change the equity?

To change equity, Nextgen Biomed can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Nextgen Biomed pay?

Over the past 12 months, Nextgen Biomed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nextgen Biomed is expected to pay a dividend of 0 ILS.

What is the dividend yield of Nextgen Biomed?

The current dividend yield of Nextgen Biomed is .

When does Nextgen Biomed pay dividends?

Nextgen Biomed pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nextgen Biomed?

Nextgen Biomed paid dividends every year for the past 0 years.

What is the dividend of Nextgen Biomed?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nextgen Biomed located?

Nextgen Biomed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nextgen Biomed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nextgen Biomed from 4/13/2025 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 4/13/2025.

When did Nextgen Biomed pay the last dividend?

The last dividend was paid out on 4/13/2025.

What was the dividend of Nextgen Biomed in the year 2024?

In the year 2024, Nextgen Biomed distributed 0 ILS as dividends.

In which currency does Nextgen Biomed pay out the dividend?

The dividends of Nextgen Biomed are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nextgen Biomed

Our stock analysis for Nextgen Biomed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nextgen Biomed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.